Download video

Using MIDD and Model Integrated Evidence to Support Generic Drug Development and Assessment

75 views

Simulations Plus, Inc.

3 years ago

Using MIDD and Model Integrated Evidence to Support Generic Drug Development and Assessment

Using MIDD and Model Integrated Evidence to Support Generic Drug Development and Assessment

Using MIDD and Model Integrated Evidence to Support Generic Drug Development and Assessment
29:55
Using MIDD and Model Integrated Evidence to Support Generic Drug Development and Assessment
by Simulations Plus, Inc.
Model-Integrated Evidence for Generic Drug Development – Session 1B
50:27
Model-Integrated Evidence for Generic Drug Development – Session 1B
by U.S. Food and Drug Administration
Model-Integrated Evidence for Generic Drug Development – Session 1C
1:01:02
Model-Integrated Evidence for Generic Drug Development – Session 1C
by U.S. Food and Drug Administration
Model-Integrated Evidence for Generic Drug Development – Session 1A
50:54
Model-Integrated Evidence for Generic Drug Development – Session 1A
by U.S. Food and Drug Administration
A Deep Dive: FDA’s Model-Integrated Evidence (MIE) Industry Meeting Pilot Program for Generic Drugs
2:03:33
A Deep Dive: FDA’s Model-Integrated Evidence (MIE) Industry Meeting Pilot Program for Generic Drugs
by U.S. Food and Drug Administration
The future of AI in medicine | Conor Judge | TEDxGalway
14:19
The future of AI in medicine | Conor Judge | TEDxGalway
by TEDx Talks
Clinical Investigators Training Course 2023 - Day 1
5:39:05
Clinical Investigators Training Course 2023 - Day 1
by U.S. Food and Drug Administration
Modeling and Simulation to Evaluate Intrinsic and Extrinsic Factors
5:03:04
Modeling and Simulation to Evaluate Intrinsic and Extrinsic Factors
by U.S. Food and Drug Administration
How to Demonstrate Virtual Bioequivalence for Complex Dermal Generic Drugs
58:30
How to Demonstrate Virtual Bioequivalence for Complex Dermal Generic Drugs
by Certara
Advancing Generic Drug Development: Translating Science to Approval 2024 – Day 1 – Part 1
1:33:53
Advancing Generic Drug Development: Translating Science to Approval 2024 – Day 1 – Part 1
by U.S. Food and Drug Administration
Strategic Implementation of Model-informed Drug Development (MIDD) for Regulatory Success
1:12:39
Strategic Implementation of Model-informed Drug Development (MIDD) for Regulatory Success
by Simulations Plus, Inc.
Advancing Generic Drug Development: Translating Science to Approval 2024 – Day 2 – Part 3
1:52:53
Advancing Generic Drug Development: Translating Science to Approval 2024 – Day 2 – Part 3
by U.S. Food and Drug Administration
Advancing Generic Drug Development: Translating Science to Approval 2024 – Day 1 – Part 3
1:17:23
Advancing Generic Drug Development: Translating Science to Approval 2024 – Day 1 – Part 3
by U.S. Food and Drug Administration
Advancing Generic Drug Development: Translating Science to Approval 2024 – Day 2 – Part 2
1:39:03
Advancing Generic Drug Development: Translating Science to Approval 2024 – Day 2 – Part 2
by U.S. Food and Drug Administration
Advancing Generic Drug Development: Translating Science to Approval 2024 – Day 1 – Part 2
1:12:08
Advancing Generic Drug Development: Translating Science to Approval 2024 – Day 1 – Part 2
by U.S. Food and Drug Administration
Advancing Generic Drug Development: Translating Science to Approval 2023 – Day 2 – Part 3
1:15:00
Advancing Generic Drug Development: Translating Science to Approval 2023 – Day 2 – Part 3
by U.S. Food and Drug Administration
Advancing Generic Drug Development: Translating Science to Approval 2024 – Day 1 – Part 4
1:01:38
Advancing Generic Drug Development: Translating Science to Approval 2024 – Day 1 – Part 4
by U.S. Food and Drug Administration
Regulatory Perspectives for Reliable Model Informed Drug Development (MIDD)
22:52
Regulatory Perspectives for Reliable Model Informed Drug Development (MIDD)
by Simulations Plus, Inc.
Unmet needs in regulatory science for generic drugs
57:11
Unmet needs in regulatory science for generic drugs
by Stanford
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop
15:51
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop
by U.S. Food and Drug Administration
Advancing Generic Drug Development: Translating Science to Approval 2024 (Day 1)
7:12:31
Advancing Generic Drug Development: Translating Science to Approval 2024 (Day 1)
by U.S. Food and Drug Administration
Complex Generics: Topical Products, Part 1
1:57:52
Complex Generics: Topical Products, Part 1
by U.S. Food and Drug Administration